Piermont Capital Management’s BancFirst BANF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
$1.27M Hold
25,394
0.6% 91
2018
Q3
$1.52M Sell
25,394
-1,914
-7% -$119K 0.61% 93
2018
Q2
$1.62M Buy
27,308
+1,860
+7% +$109K 0.5% 98
2018
Q1
$1.35M Buy
25,448
+550
+2% +$30K 0.45% 103
2017
Q4
$1.27M Hold
24,898
0.42% 102
2017
Q3
$1.41M Hold
24,898
0.47% 95
2017
Q2
$1.2M Sell
24,898
-6,378
-20% -$303K 0.34% 122
2017
Q1
$1.41M Sell
31,276
-2,800
-8% -$131K 0.34% 117
2016
Q4
$1.58M Buy
+34,076
New +$1.37M 0.36% 113
2016
Q3
Sell
-38,330
Closed -$1.16M 251
2016
Q2
$1.16M Hold
38,330
0.3% 126
2016
Q1
$1.09M Sell
38,330
-920
-2% -$25.8K 0.35% 104
2015
Q4
$1.15M Hold
39,250
0.37% 104
2015
Q3
$1.24M Buy
39,250
+1,390
+4% +$43.7K 0.4% 97
2015
Q2
$1.24M Buy
37,860
+1,200
+3% +$36.3K 0.37% 98
2015
Q1
$1.12M Buy
36,660
+660
+2% +$19.6K 0.34% 99
2014
Q4
$1.14M Buy
+36,000
New +$1.16M 0.41% 97

Other funds holding BANF

Piermont Capital Management's BANF Position: Q4 2018 in Review

Piermont Capital Management held its BancFirst (BANF) position steady in Q4 2018 at 25,394 shares worth $1.27M. The position accounts for 0.6% of the portfolio, ranked #91.

Piermont Capital Management first reported a position in BANF in Q4 2014 and has held it in 16 quarters since. The position peaked at $1.62M in Q2 2018. 124 funds tracked by Wall St. Rank hold BANF as of Q4 2018.

  • Piermont Capital Management held 25,394 shares of BancFirst worth $1.27M as of Q4 2018.
  • Piermont Capital Management left its BancFirst share count unchanged in Q4 2018.
  • BancFirst made up 0.6% of Piermont Capital Management's portfolio in Q4 2018, its #91 holding.
  • Piermont Capital Management first reported a position in BancFirst in Q4 2014 and has held it in 16 quarters since.
  • Piermont Capital Management's BancFirst position peaked at $1.62M in Q2 2018.
  • 124 funds tracked by Wall St. Rank held BancFirst as of Q4 2018.

Based on Piermont Capital Management's 13F filing for Q4 2018, filed 13 Feb 2019.